Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
2005-5-9
pubmed:abstractText
Nucleotide oligomerization domain 2 (NOD2) functions as a mammalian cytosolic pathogen recognition molecule, and variants have been associated with risk for Crohn disease. We recently demonstrated that NOD2 functions as an anti-bacterial factor limiting survival of intracellular invasive bacteria. To gain further insight into the mechanism of NOD2 activation and signal transduction, we performed yeast two-hybrid screening. We demonstrate that GRIM-19, a protein with homology to the NADPH dehydrogenase complex, interacts with endogenous NOD2 in HT29 cells. GRIM-19 is required for NF-kappaB activation following NOD2-mediated recognition of bacterial muramyl dipeptide. GRIM-19 also controls pathogen invasion of intestinal epithelial cells. GRIM-19 expression is decreased in inflamed mucosa of patients with inflammatory bowel diseases. GRIM-19 may be a key component in NOD2-mediated innate mucosal responses and serve to regulate intestinal epithelial cell responses to microbes.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
13
pubmed:volume
280
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19021-6
pubmed:dateRevised
2008-5-13
pubmed:meshHeading
pubmed-meshheading:15753091-Animals, pubmed-meshheading:15753091-Apoptosis Regulatory Proteins, pubmed-meshheading:15753091-COS Cells, pubmed-meshheading:15753091-Caco-2 Cells, pubmed-meshheading:15753091-Cell Line, pubmed-meshheading:15753091-Cell Line, Tumor, pubmed-meshheading:15753091-Cytosol, pubmed-meshheading:15753091-Epithelial Cells, pubmed-meshheading:15753091-Escherichia coli, pubmed-meshheading:15753091-Genes, Reporter, pubmed-meshheading:15753091-Humans, pubmed-meshheading:15753091-Immunoblotting, pubmed-meshheading:15753091-Immunoprecipitation, pubmed-meshheading:15753091-Intestinal Mucosa, pubmed-meshheading:15753091-Intestines, pubmed-meshheading:15753091-Intracellular Signaling Peptides and Proteins, pubmed-meshheading:15753091-Luciferases, pubmed-meshheading:15753091-Microscopy, Confocal, pubmed-meshheading:15753091-NADH, NADPH Oxidoreductases, pubmed-meshheading:15753091-NF-kappa B, pubmed-meshheading:15753091-Nod2 Signaling Adaptor Protein, pubmed-meshheading:15753091-Plasmids, pubmed-meshheading:15753091-Protein Binding, pubmed-meshheading:15753091-Protein Structure, Tertiary, pubmed-meshheading:15753091-RNA, Small Interfering, pubmed-meshheading:15753091-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15753091-Salmonella, pubmed-meshheading:15753091-Signal Transduction, pubmed-meshheading:15753091-Two-Hybrid System Techniques
pubmed:year
2005
pubmed:articleTitle
GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells.
pubmed:affiliation
Gastrointestinal Unit, Department of Medicine, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, N.I.H., Extramural